Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Alper H.YUKSEL who wrote (30126)	1/11/2000 4:45:00 PM
From: Cheryl Galt	Respond to of 32384

Anemic coverage? But 65-odd companies presented today. Getting a plug beat those odds. Also, I think the CBS-M writers got a fair amount of scathing letters from Yahoo LGND posters lately, that barre-of-vinegar might have been counter productive. Glad to see CBS-M didn't hold a grudge. That said, from CBS Marketwatch i NEVER expect analysis or investigative reporting -- just thin, parrot-style summaries, copied from the top of news items that fly across their desks. (Garbage in, garbage out -- as they say in my trade ... ) For several months, actual results are steadily lifting this stock -- lows and highs getting steadily higher. That's all I ask. (But in the meantime, I'll play any volatility. That way I can enjoy watching and owning LGND -- plus make nice short-term profits that go to purchase more shares.) Naive maybe, but it's worked so far ... This is the fourth time I've watched the H&Q pattern unfold. Will the current vogue for biotech change the pattern this year? Will the H&Q gains stick this year? If so, for which types of biotechs? These are things I'm trying to observe ... Regards, Cheryl